---
figid: PMC9392570__IJBMS-25-882-g001
pmcid: PMC9392570
image_filename: IJBMS-25-882-g001.jpg
figure_link: /pmc/articles/PMC9392570/figure/F1/
number: Figure 1
figure_title: ''
caption: 'AS-IV treatment improves ovarian injury, abnormalities of serum hormone
  levels, and the estrous cycle in PCOS rats (A) Chemical formula of AS-IV. (B) The
  estrous cycle of rats before and after AS-IV treatment. (C) Pathological injury
  level of rat ovaries before and after AS-IV treatment observed through HE staining.
  (D-G) levels of LH, FASH, LH/FSH, and testosterone in rat serum before and after
  AS-IV treatment, detected by ELISA. Data are expressed as mean ± SD. ***P<0.001
  versus Control. ##P<0.01, ###P<0.001 versus the PCOS group. @@P<0.01, @@@P<0.001
  versus the +AS-IV 20 mg/kg group. &&P<0.01, &&&P<0.001 versus the +AS-IV 40 mg/kg
  group'
article_title: Astragaloside IV regulates autophagy-mediated proliferation and apoptosis
  in a rat model of PCOS by activating the PPARγ pathway.
citation: Mingxiao Wen, et al. Iran J Basic Med Sci. 2022 Jul;25(7):882-889.
year: '2022'

doi: 10.22038/IJBMS.2022.64475.14179
journal_title: Iranian Journal of Basic Medical Sciences
journal_nlm_ta: Iran J Basic Med Sci
publisher_name: Mashhad University of Medical Sciences

keywords:
- Apoptosis
- Astragaloside IV
- Autophagy
- Polycystic ovary syndrome
- PPARγ
- Rat

---
